A Filipino-Israeli pharmaceutical company looks to invest more than P1 billion to produce a Covid-19 oral vaccine in the country, the Philippine Economic Zone Authority (PEZA) said on Thursday.

In a Viber message, PEZA Director General Charito Plaza told The Manila Times that the “estimated initial capital investment is P1.4 billion,” and said the firm targeted to establish a facility for it at the Pampanga Economic Zone.